Table 2 Treatment-related adverse events (TRAEs)
TRAEs, n (%) | Any grade | Grade 1–2 | Grade 3–4 |
|---|---|---|---|
Alopecia | 48 (100.0) | 48 (100.0) | 0 |
Nausea/vomiting | 29 (60.4) | 29 (60.4) | 0 |
Fatigue | 24 (50.0) | 24 (50.0) | 0 |
Peripheral neuropathy | 16 (33.3) | 15 (31.3) | 1 (2.1) |
Pain (lymph node, oral)a | 15 (31.3) | 15 (31.3) | 0 |
RCCEP | 14 (29.2) | 14 (29.2) | 0 |
Skin (rash, dryness, dermatitis)b | 10 (20.8) | 10 (20.8) | 0 |
Anemia | 7 (14.6) | 7 (14.6) | 0 |
Constipation | 6 (12.5) | 6 (12.5) | 0 |
Fever | 5 (10.4) | 5 (10.4) | 0 |
Leukopenia | 5 (10.4) | 5 (10.4) | 0 |
Thrombocytopenia | 4 (8.3) | 4 (8.3) | 0 |
Oral mucositis/lichenoid reaction/dry mouth/dysphagia | 3 (6.3) | 3 (6.3) | 0 |
Pneumonitis | 2 (4.2) | 1 (2.1) | 1 (2.1) |
Diarrhea | 2 (4.2) | 2 (4.2) | 0 |
